Clinical Trials · NCT02313220
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Uppsala University
- Enrollment
- 50
- Start date
- Dec 2014
- Locations
- 1 site, Sweden
- Primary endpoint
- Body weight (kg)